Home › Funds › Haven Capital Group, Inc. › IOVA
Haven Capital Group, Inc. position in IOVA
IOVANCE BIOTHERAPEUTICS INC · Health Care
Haven Capital Group, Inc. reported holding 59,143 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$876K, representing 0.67% of its reported portfolio and ranking #25 among its reported holdings. Haven Capital Group, Inc. has disclosed IOVA holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Haven Capital Group, Inc.'s IOVA position evolved
Haven Capital Group, Inc. first disclosed a stake in IOVA in Q4 2024 at 124,449 shares (US$921K). Across 7 filings, Haven Capital Group, Inc. increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 59,143 shares valued at US$876K. Notable position changes include a 29% trim in Q3 2025 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 124.45K | $920.92K | New |
| Q1 2025 | 121.91K | $406.00K | Reduce |
| Q2 2025 | 106.51K | $183.00K | Reduce |
| Q3 2025 | 75.50K | $164.00K | Reduce |
| Q4 2025 | 59.14K | $161.00K | Reduce |
| Q1 2026 | 59.14K | $207.59K | Hold |
| Q3 2026 | 59.14K | $876.50K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IOVA and 13F data
IOVA (IOVANCE BIOTHERAPEUTICS INC) is a Health Care company. 28 other funds we track also report a position in IOVA — the largest reported positions include MHR FUND MANAGEMENT LLC (US$120.5M), Palo Alto Investors LP (US$22.0M), Mirador Capital Partners LP (US$16.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IOVA
- MHR FUND MANAGEMENT LLC 28.97M sh · $120.50M · Q2 2026
- Palo Alto Investors LP 5.30M sh · $22.03M · Q2 2026
- Mirador Capital Partners LP 1.10M sh · $16.24M · Q3 2026
More on Haven Capital Group, Inc.
FAQ
How long has Haven Capital Group, Inc. held IOVA?
Haven Capital Group, Inc. has disclosed IOVA holdings in 7 of the last 8 reported quarters, going back to Q4 2024.
What is Haven Capital Group, Inc.'s current position in IOVA?
As of Q3 2026, Haven Capital Group, Inc. holds 59.14K shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $876.50K, representing 0.67% of its reported portfolio and ranking #25.
Has Haven Capital Group, Inc. been buying or selling IOVA?
In the latest 13F filing (Q3 2026), Haven Capital Group, Inc. newly opened its position in IOVA.
Which other funds hold IOVA?
Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, Palo Alto Investors LP, Mirador Capital Partners LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.